Francine Marques is an Australian medical researcher. A professor of genetics and genomics at Monash University, she is a Sylvia and Charles Viertel Charitable Foundation Fellow, NHMRC Emerging Leader, and a Heart Foundation Future Leader Fellow, known for her work on the effects of gut microbes on high blood pressure.
Francine Marques completed her bachelor's degree in Genetics, and Masters in Molecular Biology and Genetics, at the Federal University of Rio Grande do Sul in Brazil. After moving to Australia, she completed her PhD at the University of Sydney in 2012, supported by an Endeavour International Postgraduate Research Scholarship. She established her research laboratory at Monash University in 2018. She was appointed as a Senior Lecturer in 2014, Associate Professor in 2021, and full Professor in 2024. As of 2024 [update] , she is a professor at Monash University and a Sylvia and Charles Viertel Charitable Foundation Fellow, NHMRC Emerging Leader, and a Heart Foundation Future Leader Fellow. She is widely recognised for her research on hypertension and the microbiome. Her contributions have enhanced our understanding of the effects of dietary fibre on blood pressure, and how the modulation of bacteria in our gut can improve heart health. [1]
Marques investigates the molecular mechanisms behind the development of high blood pressure, with focus on disease identification, prevention and treatment through manipulation of gut microbes and their metabolites. Her research has shown that a diet reach in fibre is able to lower blood pressure and improve heart function through the modulation of the bacteria in our gut. [1]